SCHEMBL22402089

SCHEMBL22402089

O=C(Nc1cc(C(=O)Nc2c(I)cc(C(F)(C(F)(F)F)C(F)(F)F)cc2C(F)(F)F)ccc1F)c1ccc(F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.44
HDAC8 Q9BY41 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
HTR1F P30939 1/20 0.41
RAB9A P51151 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PPARG P37231 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
KCNJ11 Q14654 1/20 0.39
KCNMA1 Q12791 1/20 0.39
BRAF P15056 1/20 0.38
KCNQ3 O43525 1/20 0.38
KCNQ2 O43526 1/20 0.38
KCNE1 P15382 1/20 0.38
KCNQ1 P51787 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1766384 0.85 MEN1 (0.50) RAB9AMEN1KMT2ANPC1PTGS1
SCHEMBL1766587 0.84 CA12 (0.43) HTR1FCYP1A2CYP2D6CYP2C19MEN1
SCHEMBL20846834 0.83 TACR1 (0.39) HDAC8RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL29549701 0.82 HDAC1 (0.48) HDAC1HDAC8HDAC6RAB9AMEN1
SCHEMBL1766812 0.81 HDAC1 (0.56) HDAC1HDAC8HDAC6RAB9ACYP1A2
SCHEMBL1767397 0.81 KCNK3 (0.47) RAB9AMEN1KMT2ANPC1PTGS1
SCHEMBL20846832 0.80 RXFP1 (0.39) PPARGNR1H4PTGS1
SCHEMBL1766565 0.79 CA12 (0.41) HTR1FCYP1A2CYP2D6CYP2C19MEN1
SCHEMBL1766685 0.79 MAPT (0.41) HDAC1HDAC8HDAC6CYP1A2MEN1
SCHEMBL1767276 0.78 MEN1 (0.50) RAB9AMEN1KMT2AKCNJ11NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230226037-A1 PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) 2023-07-20 US disclosed
US-11696913-B2 Prolonged ectoparasite-controlling agent for animal MITSUI CHEMICALS AGRO, INC. (JP) 2023-07-11 US disclosed
US-20200281914-A1 PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL MITSUI CHEMICALS AGRO, INC. (JP) 2020-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11696913-B2 Prolonged ectoparasite-controlling agent for animal MTX1, ENPP1, CAT HDAC1 565/4885HDAC8 2127/4885HDAC6 884/4885
US-20230226037-A1 PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL MTX1, ENPP1, CAT HDAC1 565/4885HDAC8 2127/4885HDAC6 884/4885
US-20200281914-A1 PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL MTX1, ENPP1, CAT HDAC1 565/4885HDAC8 2127/4885HDAC6 884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.